Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  sagopilone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-12 of 12 for your search:
Start Over
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91495, 2006-000067-29, 310101, NCT00359359
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91374, 2005-000586-19, 307971, NCT00160069
Efficacy and Safety Study of ZK219477 in Patients With Recurrentovarian Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91447, EudraCT No: 2005-000635-15, 307970, NCT00246688
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91464, 2005-003216-30, 309544, NCT00288249
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91466, 307975, NCT00313248
ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91476, 307979, NCT00325351
ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91500, 307976, NCT00350051
Epothilone in Recurrent Glioblastoma Patients
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: ZK219477IV, NCT00397072
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-26061, EUDRACT-2006-001659-37, SPRI-EORTC-26061, NCT00424060
Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-14965, ZK219477, 108.0701, NCT00598507
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91695, 2008-000879-26, NCT00751205
Investigation Into How the Body Takes up the Test Drug and Distributes it Into Various Body Organs and Tissues, How it Processes the Drug and How it Ultimately Removes it
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91490, 2006-000188-26, 310301, NCT00432302
Start Over